Skip to main content
Fig. 6 | Cancer Cell International

Fig. 6

From: Integrated proteomics and metabolomics analyses reveal new insights into the antitumor effects of valproic acid plus simvastatin combination in a prostate cancer xenograft model associated with downmodulation of YAP/TAZ signaling

Fig. 6

Schematic representation of the metabolic mechanisms modulated in the 22Rv1 VPA/SIM-treated and CTR groups. Metabolic mechanisms altered in the 22Rv1 xenograft tumor samples treated with VPA/SIM compared with those in the control (CTR) group. The enzymes and metabolites highlighted in red are those whose levels increased, whereas the enzymes highlighted in green are those whose levels decreased in the 22Rv1 VPA/SIM-treated group. The figure was created using https://www.BioRender.com

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us